Is a complete FRA/3AC research report available?

No complete published report is available for fra/3AC (FRA/3AC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/3AC (FRA/3AC)

Frankfurt Stock Exchange: FRA/3AC · EUR

€0.02

+0.00 (+1.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/3AC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	91.3M
Revenue (ttm)	4.2M
Net income (ttm)	-10.2M
EPS (ttm)	-€0.00
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.2M
Net income (ttm): -10.2M
EPS (ttm): -€0.00
Market cap: 91.3M

All FRA/3AC indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

AUD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	DE
Employees	6
Enterprise value	EUR 87.4M
Exchange	Frankfurt Stock Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 91.3M
Price	EUR 0.02
Price currency	EUR
Rev Per Employee	697,227.33x
Sic	2836
Symbol	fra/3AC
Website	https://actinogen.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.15%
EV/Sales	19.51x
FCF yield	-10.24%
P/B ratio	19.2x
P/S ratio	21.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-249.87%
EBITDA Margin	-245.12%
Gross margin	100%
Gross Profit	EUR 4.2M
Gross Profit Growth	-18.38%
Gross Profit Growth3 Y	16.61%
Gross Profit Growth5 Y	21.1%
Net Income	EUR -10.2M
Pretax Margin	-243.22%
Profit Margin	-243.22%
Profit Per Employee	EUR -1.7M
ROA	-63.83
Roa5y	-33.54
ROCE	-216.2
ROE	-110.8
Roe5y	-58.71
ROIC	-70.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-7.1%
Cagr15y	-3.71%
Cagr1y	17.66%
Cagr3y	4.5%
Cagr5y	-21.09%
Revenue Growth	-18.38x
Revenue Growth3 Y	16.61x
Revenue Growth5 Y	21.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.41
Assets	EUR 6M
Cash	EUR 3.7M
Current Assets	EUR 5.3M
Current Liabilities	EUR 1.3M
Debt	EUR 127,192
Debt Equity	EUR 0.03
Debt FCF	EUR -0.01
Equity	EUR 4.8M
Interest Coverage	-101.6
Liabilities	EUR 1.3M
Long Term Assets	EUR 693,959
Long Term Liabilities	EUR -3,421
Net Cash	EUR 3.6M
Net Cash By Market Cap	EUR 3.93
Net Cash Growth	-72.06%
Net Debt Equity	EUR -0.75
Tangible Book Value	EUR 3.8M
Tangible Book Value Per Share	EUR 0

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.19
Net Working Capital	EUR 123,621
Quick ratio	4.17
Working Capital	EUR 3.8M
Working Capital Turnover	EUR 0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-52.13%
1Y total return	17.65%
200-day SMA	0.02
3Y total return	14.12%
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.4%
All Time High	0.16
All Time High Change	-87.18%
All Time High Date	2010-10-08
All Time Low	0
All Time Low Change	19,900%
All Time Low Date	2019-06-11
ATR	0
Ch YTD	-31.03
High	0.02
High52	0.05
High52 Date	2026-01-08
High52ch	-55.11%
Low	0.02
Low52	0.01
Low52 Date	2025-08-01
Low52ch	83.64%
Ma50ch	-2.91%
Price vs 200-day SMA	-14.16%
RSI	47.06
RSI Monthly	48.85
RSI Weekly	47.82
Sharpe ratio	0.84x
Sortino ratio	1.33
Total Return	-19.06%
Tr YTD	-31.03
Tr15y	-43.31%
Tr1m	-4.76%
Tr1w	-2.91%
Tr3m	-20%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -10.5M
Operating margin	-249.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,045,015,391%
Net Borrowing	-130,803.2
Shares Insiders	12.54%
Shares Institutions	3.08%
Shares Qo Q	3.62%
Shares Yo Y	19.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -10.3M
Adjusted OCF	-10,269,314
Average Volume	6,491.65x
Bv Per Share	0
CAPEX	EUR -21,800
Ch10y	-55.56
Ch15y	-47.37
Ch1m	-4.76
Ch1w	-2.91
Ch1y	17.65
Ch3m	-20
Ch3y	8.11
Ch5y	-71.01
Ch6m	-18.37
Change	1%
Change From Open	0
Close	0.02
Days Gap	1
Depreciation Amortization	212,573.8
Earnings Date	2026-08-28
EBIT	EUR -10.5M
EBITDA	EUR -10.3M
EPS	EUR -0
F Score	1
FCF	EUR -9.3M
FCF EV Yield	-10.69x
Financing CF	66,268
Fiscal Year End	June
Founded	1,999
Investing CF	-21,800
Is Primary Listing	0
Last Earnings Date	2026-02-19
Last Report Date	2025-12-31
Last Split Date	2013-12-03
Last Split Type	Reverse
Ma150	0.02
Ma150ch	-13.42%
Ma20	0.02
Ma20ch	-5.66%
Net CF	-9,279,690
Next Earnings Date	2026-08-28
Open	0.02
Ppne	132,913.9
Price Date	2026-07-30
Ptbv Ratio	23.83
Relative Volume	2.31x
Revenue	4,183,364x
SBC By Revenue	22.59x
Share Based Comp	945,156
Tr6m	-18.37%
Volume	0
Z Score	8.82

FRA/3AC (FRA/3AC)

Coverage state: Market snapshot only — no published research

Generate the first FRA/3AC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/3AC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/3AC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/3AC

Frequently asked questions